Jaromír Zahrádka is CEO of the i&i Biotech Fund, an early-phase biotech investment fund focusing on technologies and startups originated at CEE research institutes and universities. The fund has more than EUR 47 m under management, and it already invested into 7 startups from 5 countries. Jaromir is also a co-founder of i&i Prague, a bio-innovation centre associated to the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences. Under his leadership, both companies have developed into respected partners of several Czech and European scientific institutions, spin-offs and other international investors.
During his 10 years of experience in technology transfer and scientific equity investments, Jaromír has been involved in managing a series of successful projects including three successful exits with average multiple over 7,5 X in 2022 and 2023. Together with his team, Jaromir participated on establishment, investment, or other support of development of more than 15 biotech spin-off companies and multiple out-licensing deals based on technologies originated at research institutes from more than 8 countries. In his profession, he combines his dual background in biochemistry and economics, he is teaching at university and benefits of his deep expertise in risk-adjusted valuation of early-phase technologies.
